The future of multiple myeloma treatment: genetic tests and frailty
The main prognostic factors and why minimal residual disease is becoming crucial in multiple myeloma
The diagnosis of early T-cell precursor (ETP) ALL
Why is supportive care important in myeloma?
Debate on the use of MRD for multiple myeloma management
Bruno Paiva et al.